Global Novel Drug Delivery Systems (NDDS) Market by Route of Administration, Mode of NDDS, Geography-Growth, Trends, and Forecast (2018-2023)
Orbisresearch.com has announced the addition of Global Novel drug delivery systems Market. The report focuses on global major leading industry players with information such as company profiles, product picture and specification.
(EMAILWIRE.COM, June 04, 2018 ) Novel drug delivery systems market is expected to witness a CAGR of 2.9%, during the forecast period, 2018-2023. There is a continuous growth in the market of drug delivery systems and is forecasted to continue to grow at an impressive rate in future also.
Browse Full Report with TOC: http://orbisresearch.com/contacts/request-sample/2131526
Key Leading Major Companies Mentioned:
Abbott Laboratories, Astrazeneca Plc, Bayer Healthcare Pharmaceuticals, Glaxosmithkline Plc, Johnson & Johnson, Merck & Co., Novartis Ag, Pfizer Inc., Roche Holding Ag, Sanofi Sa
Requirement of Controlled Release of Drugs
The method by which a drug is being delivered can have significant influence on its efficacy. Many of the drugs have an optimum concentration range and requirement of controlled release of drugs in the body has to be there. The concentrations above or below the concentration range can be toxic or can produce no therapeutic benefits at all. Transdermal patches, implants, nasal systems, microcapsules, etc. are some of the common systems that are considered under the controlled release systems. Hence, the requirement of controlled release of drugs leads to drive the novel drug delivery systems market.
The other factors include advancement in pharmacology promoting increased adoption of novel drug delivery systems (NDDS) and technological advancements promoting development of NDDS.
Stability Issues with the NDDS System
The stability of the delivery system is one of the most important factors, which effects the drug delivery systems market. Liposomes are the most common nanocarriers for drug delivery owing to the several advantages they offer over other delivery systems. Liposomes help in stabilizing therapeutic compounds and improved biodistribution of compounds to target sites in vivo. However, stability of liposome-based drug delivery systems is a major concern, which is restraining the growth of this market.
The other restraining factors also include the stringent regulatory guidelines and product recalls.
North America Dominates the Market
North America has dominated the novel drug delivery systems in cancer therapy market in 2016 with a revenue share of around 37%. North America holds the major share in the market owing to the factors, such as growing R&D in the field of drug delivery systems, the high adoption rate of new technologies, and supportive reimbursement policies. Asia Pacific is also expected to witness growth in the novel drug delivery systems market in the upcoming future.
Key Developments in the Market
November 2017: Juluca (dolutegravir and rilpivirine) approved in US as first 2-drug regimen, once-daily, single pill a complete regimen for the maintenance treatment of virologically suppressed HIV-1 infection
Reasons to Purchase this Report
Current and future novel drug delivery systems market outlook in the developed and emerging markets
Analyzing various perspectives of the market with the help of Porter’s five forces analysis
The segment that is expected to dominate the market
Regions that are expected to witness fastest growth during the forecast period
Identify the latest developments, market shares, and strategies employed by the major market players
3 months analyst support, along with the Market Estimate sheet (in Excel)
Enquire before Buying at http://orbisresearch.com/contacts/enquiry-before-buying/2131526
Customization of the Report
This report can be customized to meet your requirements. Please connect with our analyst, who will ensure you get a report that suits your needs
About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Browse Full Report with TOC: http://orbisresearch.com/contacts/request-sample/2131526
Key Leading Major Companies Mentioned:
Abbott Laboratories, Astrazeneca Plc, Bayer Healthcare Pharmaceuticals, Glaxosmithkline Plc, Johnson & Johnson, Merck & Co., Novartis Ag, Pfizer Inc., Roche Holding Ag, Sanofi Sa
Requirement of Controlled Release of Drugs
The method by which a drug is being delivered can have significant influence on its efficacy. Many of the drugs have an optimum concentration range and requirement of controlled release of drugs in the body has to be there. The concentrations above or below the concentration range can be toxic or can produce no therapeutic benefits at all. Transdermal patches, implants, nasal systems, microcapsules, etc. are some of the common systems that are considered under the controlled release systems. Hence, the requirement of controlled release of drugs leads to drive the novel drug delivery systems market.
The other factors include advancement in pharmacology promoting increased adoption of novel drug delivery systems (NDDS) and technological advancements promoting development of NDDS.
Stability Issues with the NDDS System
The stability of the delivery system is one of the most important factors, which effects the drug delivery systems market. Liposomes are the most common nanocarriers for drug delivery owing to the several advantages they offer over other delivery systems. Liposomes help in stabilizing therapeutic compounds and improved biodistribution of compounds to target sites in vivo. However, stability of liposome-based drug delivery systems is a major concern, which is restraining the growth of this market.
The other restraining factors also include the stringent regulatory guidelines and product recalls.
North America Dominates the Market
North America has dominated the novel drug delivery systems in cancer therapy market in 2016 with a revenue share of around 37%. North America holds the major share in the market owing to the factors, such as growing R&D in the field of drug delivery systems, the high adoption rate of new technologies, and supportive reimbursement policies. Asia Pacific is also expected to witness growth in the novel drug delivery systems market in the upcoming future.
Key Developments in the Market
November 2017: Juluca (dolutegravir and rilpivirine) approved in US as first 2-drug regimen, once-daily, single pill a complete regimen for the maintenance treatment of virologically suppressed HIV-1 infection
Reasons to Purchase this Report
Current and future novel drug delivery systems market outlook in the developed and emerging markets
Analyzing various perspectives of the market with the help of Porter’s five forces analysis
The segment that is expected to dominate the market
Regions that are expected to witness fastest growth during the forecast period
Identify the latest developments, market shares, and strategies employed by the major market players
3 months analyst support, along with the Market Estimate sheet (in Excel)
Enquire before Buying at http://orbisresearch.com/contacts/enquiry-before-buying/2131526
Customization of the Report
This report can be customized to meet your requirements. Please connect with our analyst, who will ensure you get a report that suits your needs
About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Contact Information:
Orbis Research
Hector Costello
Tel: +1 (214) 884-6817
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Orbis Research
Hector Costello
Tel: +1 (214) 884-6817
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results